This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe

ONLINE REGISTRATION CLOSES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Delivered as a Hybrid Event, 7 - 9 June, 2022
Live In-Person Event: 7 - 9 June, Postillion Hotel AmsterdamDigital Experience: All Sessions Livestreamed 7 - 9 June

Aneesh Karatt-Vellatt, PhD
Chief Scientific Officer at Maxion Therapeutics

Profile

Dr. Aneesh Karatt-Vellatt is Chief Scientific officer and co-founder at Maxion Therapeutics Ltd, a company focused on developing antibody treatments for diseases driven by ion channels and GPCRs. Dr Karatt Vellatt was also co-founder of IONTAS Ltd and holds a PhD in Biochemistry from the University of Cambridge.

Agenda Sessions

  • Generation of Antibody-like Modulators of Ion Channels by Fusing Cysteine Rich Miniproteins into Peripheral CDR Loops

    11:20